- FDA has found that in this and past foodborne illness outbreak investigations "suggest that a likely contributing factor for contamination of leafy greens has been the proximity of cattle."
- FDA "recommends that all growers be aware of and consider adjacent land use practices, especially as it relates to the presence of livestock, and the interface between farmland, rangeland and other agricultural areas, and conduct appropriate risk assessments and implement risk mitigation strategies, where appropriate."
- "The 2020 E. coli O157:H7 outbreak associated with leafy greens represents the latest in a repeated series of outbreaks associated with leafy greens that originated in the Central Coast of California (encompassing Salinas Valley and Santa Maria) growing region."
- FDA "recommends that growers of leafy greens in the California Central Coast Growing Region consider this reoccurring E. coli strain a reasonably foreseeable hazard, and specifically of concern in the South Monterey County area of the Salinas Valley."
- FDA "also recommends that the agricultural community in the California Central Coast growing region work to identify where this reoccurring strain of pathogenic E. coli is persisting and the likely routes of leafy green contamination with STEC."
- FDA "alone cannot fix this issue. Industry leadership and collaboration among growers, processors, retailers, state partners and the broader agricultural community is critical to reducing foodborne illnesses. "
FDA Leafy Greens STEC Action Plan
https://www.fda.gov/news-events/press-announcements/fda-releases-investigation-report-following-fall-2020-outbreak-e-coli-o157h7-illnesses-linked-leafy
FDA Releases Investigation Report Following Fall 2020 Outbreak of E. coli O157:H7 Illnesses Linked to Leafy Greens
Agency affirms need for new collaborative actions to build on accomplishments in its Leafy Greens Shiga Toxin-Producing E. coli (STEC) Action Plan